Abstract:Sleep disturbances are common in adults with PTSD and range from insomnia and nightmares to periodic leg movements and disruptive nocturnal behaviors. Together these findings suggest profound disturbances in rapid eye movement (REM) and non-REM (NREM) sleep, although there is a lack of consensus regarding a distinct profile of objective sleep disturbances associated with PTSD. Prospective, longitudinal studies have established that sleep disturbances represent a risk factor for the development and course of PT… Show more
“…Regarding the temporal association between sleep disturbance and PTSD severity, studies have supported similar effects of sleep disturbance on PTSD symptomatology, as reported in the current study in both civilian and military populations (Breslau et al, 2004;Miller et al, 2017). It has also been proposed that treating sleep problems directly is beneficial for both civilians and military populations with PTSD (Brownlow, Harb & Ross, 2016;Koffel et al, 2016).…”
Section: Discussionsupporting
confidence: 84%
“…We were also unable to assess nightmare frequency or intensity in our cohort as our independent measure of sleep disturbance (i.e., the JSS did not include any nightmarerelated items). The prevalence of nightmares and their relation to PTSD severity and outcomes is an important and relatively unexplored topic for future research (Cox et al, 2017;Koffel et al, 2016;Miller et al, 2017). Finally, although we report on a high rate of prescriptions given for sedative-hypnotic drugs, we did not assess the use of other psychotropic drugs, such as benzodiazepines, tricyclic antidepressants, opiates, or nonprescription sleep aids.…”
Section: Discussionmentioning
confidence: 95%
“…Previous studies have failed to adequately address the role of gender in PTSD-related sleep disturbances (Koffel et al, 2016;Miller et al, 2017), although some authors have proposed that female veterans with PTSD may have increased susceptibility to sleep difficulties in light of higher rates of insomnia generally in women (Cox et al, 2017;Miller et al, 2017), although evidence for this hypothesis has been scant. In our study, we observed similarly high rates of insomnia and nonrestorative sleep complaints in male and female, combat-exposed veterans with PTSD.…”
Section: Discussionmentioning
confidence: 99%
“…From a neurobiological perspective, it has been proposed that chronic sleep loss can lead to emotional dysregulation (Koffel et al, 2016) or heightened autonomic arousal (Miller et al, 2017), which in turn may be a risk factor for PTSD in trauma-exposed individuals (Cox et al, 2017). It has also been proposed that prior sleep disturbance may attenuate the effects of extinction learning, leading to more enduring or severe symptoms in trauma-exposed individuals with concomitant sleep disorders (Brownlow, Harb & Ross, 2015;Miller et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, given the prominent role of depression, traumatic brain injury (TBI), and other prevalent comorbidities in combat-exposed veterans (Green et al, 2016;Holowka et al, 2014;Rosen et al, 2012) and the significant risk for both PTSD and sleep disturbance associated with each of these comorbidities (Kessler et al, 2011;Sarsour et al, 2010), the role of comorbidities may be central to understanding the association. Third, the role of gender as a potential risk factor or moderator of sleep symptoms among veterans has not been adequately addressed in prior studies (Koffel et al, 2016). This is a key omission as women in the general population have a higher risk for insomnia-related sleep complaints (Sarsour et al, 2010) and higher rates of prescription drug use for insomnia than men (Bertisch et al, 2014;Kessler et al, 2011).…”
Few studies have investigated the range and severity of insomnia-related sleep complaints among veterans with posttraumatic stress disorder (PTSD), and the temporal association between insomnia and PTSD severity has yet to be examined. To examine these associations, a large, gender-balanced cohort of veterans (N = 1,649) of the Iraq and Afghanistan conflicts participated in longitudinal assessments of PTSD and insomnia-related symptoms over a period of 2.5 years following enrollment (range: 2-4 years). Data were obtained from multiple sources, including interviews, self-report assessments, and electronic medical record data. Three-fourths (74.0%) of veterans with PTSD diagnoses at Time 1 (T1) reported insomnia-related sleep difficulties on at least half the nights during the past 30 days, and one-third of participants had received a prescription for a sedative-hypnotic drug in the past year. Veterans without PTSD had fewer sleep problems overall, although the prevalence of sleep problems was high among all study participants. In longitudinal, cross-lagged panel models, the frequency of sleep problems at T1 independently predicted increases in PTSD severity at Time 2 (T2), B = 0.27, p < .001, after controlling for gender and relevant comorbidities. Conversely, T1 PTSD severity was associated with increasing sleep complaints at T2 but to a lesser degree, B = 0.04, p < .001. Moderately high rates of sedative-hypnotic use were seen in veterans with PTSD, with more frequent use in women compared to men (40.4% vs. 35.0%). Sleep complaints were highly prevalent overall and highlight the need for increased clinical focus on this area.
“…Regarding the temporal association between sleep disturbance and PTSD severity, studies have supported similar effects of sleep disturbance on PTSD symptomatology, as reported in the current study in both civilian and military populations (Breslau et al, 2004;Miller et al, 2017). It has also been proposed that treating sleep problems directly is beneficial for both civilians and military populations with PTSD (Brownlow, Harb & Ross, 2016;Koffel et al, 2016).…”
Section: Discussionsupporting
confidence: 84%
“…We were also unable to assess nightmare frequency or intensity in our cohort as our independent measure of sleep disturbance (i.e., the JSS did not include any nightmarerelated items). The prevalence of nightmares and their relation to PTSD severity and outcomes is an important and relatively unexplored topic for future research (Cox et al, 2017;Koffel et al, 2016;Miller et al, 2017). Finally, although we report on a high rate of prescriptions given for sedative-hypnotic drugs, we did not assess the use of other psychotropic drugs, such as benzodiazepines, tricyclic antidepressants, opiates, or nonprescription sleep aids.…”
Section: Discussionmentioning
confidence: 95%
“…Previous studies have failed to adequately address the role of gender in PTSD-related sleep disturbances (Koffel et al, 2016;Miller et al, 2017), although some authors have proposed that female veterans with PTSD may have increased susceptibility to sleep difficulties in light of higher rates of insomnia generally in women (Cox et al, 2017;Miller et al, 2017), although evidence for this hypothesis has been scant. In our study, we observed similarly high rates of insomnia and nonrestorative sleep complaints in male and female, combat-exposed veterans with PTSD.…”
Section: Discussionmentioning
confidence: 99%
“…From a neurobiological perspective, it has been proposed that chronic sleep loss can lead to emotional dysregulation (Koffel et al, 2016) or heightened autonomic arousal (Miller et al, 2017), which in turn may be a risk factor for PTSD in trauma-exposed individuals (Cox et al, 2017). It has also been proposed that prior sleep disturbance may attenuate the effects of extinction learning, leading to more enduring or severe symptoms in trauma-exposed individuals with concomitant sleep disorders (Brownlow, Harb & Ross, 2015;Miller et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, given the prominent role of depression, traumatic brain injury (TBI), and other prevalent comorbidities in combat-exposed veterans (Green et al, 2016;Holowka et al, 2014;Rosen et al, 2012) and the significant risk for both PTSD and sleep disturbance associated with each of these comorbidities (Kessler et al, 2011;Sarsour et al, 2010), the role of comorbidities may be central to understanding the association. Third, the role of gender as a potential risk factor or moderator of sleep symptoms among veterans has not been adequately addressed in prior studies (Koffel et al, 2016). This is a key omission as women in the general population have a higher risk for insomnia-related sleep complaints (Sarsour et al, 2010) and higher rates of prescription drug use for insomnia than men (Bertisch et al, 2014;Kessler et al, 2011).…”
Few studies have investigated the range and severity of insomnia-related sleep complaints among veterans with posttraumatic stress disorder (PTSD), and the temporal association between insomnia and PTSD severity has yet to be examined. To examine these associations, a large, gender-balanced cohort of veterans (N = 1,649) of the Iraq and Afghanistan conflicts participated in longitudinal assessments of PTSD and insomnia-related symptoms over a period of 2.5 years following enrollment (range: 2-4 years). Data were obtained from multiple sources, including interviews, self-report assessments, and electronic medical record data. Three-fourths (74.0%) of veterans with PTSD diagnoses at Time 1 (T1) reported insomnia-related sleep difficulties on at least half the nights during the past 30 days, and one-third of participants had received a prescription for a sedative-hypnotic drug in the past year. Veterans without PTSD had fewer sleep problems overall, although the prevalence of sleep problems was high among all study participants. In longitudinal, cross-lagged panel models, the frequency of sleep problems at T1 independently predicted increases in PTSD severity at Time 2 (T2), B = 0.27, p < .001, after controlling for gender and relevant comorbidities. Conversely, T1 PTSD severity was associated with increasing sleep complaints at T2 but to a lesser degree, B = 0.04, p < .001. Moderately high rates of sedative-hypnotic use were seen in veterans with PTSD, with more frequent use in women compared to men (40.4% vs. 35.0%). Sleep complaints were highly prevalent overall and highlight the need for increased clinical focus on this area.
Posttrauma nightmares are recurring nightmares that begin after a traumatic experience and can occur as often as multiple times per week, often in a seemingly random pattern. Although these nightmares are prevalent in trauma survivors, little is known about the mechanisms underlying their sporadic occurrence. The present study aimed to investigate predictors of posttrauma nightmares. The sample included 146 observations nested within 27 female college students who reported frequent nightmares related to sexual trauma. Participants were recruited from an undergraduate student subject pool (n = 71) or were clinical referrals (n = 75). Participants completed an initial assessment battery and six consecutive days of pre‐ and postsleep diaries, which included measures of potential posttrauma nightmare triggers and measures intended to assess sleep quality and posttrauma nightmare occurrence. Descriptive statistics, mean comparisons, and multilevel modeling were used to examine the data. The results showed that both presleep cognitive arousal, γ10SLij = 0.58, p = .006, z(1, N = 146) = −2.61; and sleep latency (SL), γ20PCAij = 0.76, p < .001, z(1, N = 146) = −2.69, predicted posttrauma nightmare occurrence. Further investigation suggested that presleep cognitive arousal moderated the relation between SL and posttrauma nightmare occurrence, γ30PCA x SLij = 0.67, p = .048 z(1, N = 146) = 1.98. The present results are the first to show that the co‐occurrence of presleep arousal and delayed sleep onset latency may influence posttrauma nightmare occurrence, suggesting that the time immediately before sleep is crucial to the production of the posttrauma nightmares.
Sleep disturbances (SDs) are among the most distressing and commonly reported symptoms in posttraumatic stress disorder (PTSD). Despite increased attention on sleep in clinical PTSD research, SDs remain difficult to treat. In Phase 2 trials, 3,4‐methylenedioxymethamphetamine (MDMA)–assisted psychotherapy has been shown to greatly improve PTSD symptoms. We hypothesized that MDMA‐assisted psychotherapy would improve self‐reported sleep quality (SQ) in individuals with PTSD and be associated with declining PTSD symptoms. Participants in four studies (n = 63) were randomized to receive 2–3 sessions of active MDMA (75–125 mg; n = 47) or placebo/control MDMA (0–40 mg, n = 16) during all‐day psychotherapy sessions. The PSQI was used to assess change in SQ from baseline to the primary endpoint, 1–2 months after the blinded sessions. Additionally, PSQI scores were measured at treatment exit (TE) and 12‐month follow‐up. Symptoms of PTSD were measured using the CAPS‐IV. At the primary endpoint, CAPS‐IV total severity scores dropped more after active MDMA than after placebo/control (−34.0 vs. −12.4), p = .003. Participants in the active dose group showed more improvement in SQ compared to those in the control group (PSQI total score ΔM = −3.5 vs. 0.6), p = .003. Compared to baseline, SQ had improved at TE, p < .001, with further significant gains reported at 12‐month follow‐up (TE to 12‐months ΔM = −1.0), p = .030. Data from these randomized controlled double‐blind studies provide evidence for the beneficial effects of MDMA‐assisted psychotherapy in treating SDs in individuals with PTSD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.